A group of researchers at the University of Seattle have managed for the first time to develop in vitro blood stem cells. In the recent hormonal company known as thrombopoietin, these cells develop in a few weeks. When these stem cells were introduced to very sick mice, researchers observed how their blood was recovered. After a year, the immunity system of mice seemed completely normal.
Although the finding is still in a preliminary phase, the news is encouraging for patients treated with chemotherapy and radiation therapy.